Company Filing History:
Years Active: 2003
Title: The Innovations of Robert E. Lagace
Introduction
Robert E. Lagace is a notable inventor based in Belmont, California. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acids and their applications. His work has implications for diagnostics and therapeutic compositions, showcasing the potential of genetic research.
Latest Patents
Robert E. Lagace holds a patent for "Nucleic acids encoding 3-ketoacyl-ACP reductase from Moraxella catarrahalis." This invention provides genomic sequences of a library of purified nucleic acid molecules, or their complements, comprising the genome of Moraxella catarrahalis. The patent also identifies open reading frames contained within these nucleic acid molecules. Furthermore, it outlines the use of these nucleic acid molecules, their complements, or fragments, along with proteins or portions thereof, for identifying ligands and developing useful diagnostic and therapeutic compositions. The invention also includes vectors, host cells, and methods for producing proteins or portions thereof.
Career Highlights
Robert E. Lagace is associated with Elitra Pharmaceuticals Inc., where he has contributed to various innovative projects. His expertise in biotechnology has been instrumental in advancing the company's research initiatives.
Collaborations
He has worked alongside notable colleagues such as Chandra Patterson and Kim L. Berg, contributing to a collaborative environment that fosters innovation and discovery.
Conclusion
Robert E. Lagace's work exemplifies the intersection of biotechnology and innovation. His contributions, particularly in the realm of nucleic acids, continue to influence the field and pave the way for future advancements.